Atlas Trials

A Study of the Effectiveness and Safety of Prolonged-release Methylphenidate Hydrochloride in Adult Patients With Attention Deficit/Hyperactivity Disorder.

Clinical trial NCT00246220 · COMPLETED

Trial details

NCT number
NCT00246220
Sponsor
Janssen Pharmaceutica N.V., Belgium
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Attention Deficit Disorder With Hyperactivity
Start date
2005-03-01
Enrollment
402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.